Jin Fang1, Xiao Zhang2, Xiaoyun Liang2, Feng Huang2, and Shuixing Zhang1
1The First Affiliated Hospital of Jinan University, Guangzhou, China, 2Neusoft Medical Systems Co, Shanghai, China
Synopsis
Keywords: Uterus, Radiomics
Appropriate management and treatment decisions
for cervical cancer depend on accurate staging, but the differentiation between
IIA and IIB by imaging assessment remains difficult. This retrospective study investigated the performance of
intratumoral and peritumoral multi-parameter MRI texture information in
differentiating IIA and IIB using non-invasive radiomics analysis, which was
also compared with clinical factors and imaging assessment by radiologists. Among
all the comparisons, peritumoral-based radiomics
models outperformed the
radiologists and performed the best. This
study offers a viable approach in non-invasively and accurately differentiating
IIA and IIB for cervical cancer based on peritumoral texture information.
Introduction
Appropriate management and treatment decisions
for cervical cancer depends on accurate staging. Surgery is the
first-line treatment for early-stage cervical cancer (IA-IIA), while concurrent
chemoradiothrapy (CCRT) is the standard treatment in locally advanced cervical
cancer (IIB-IV).1 According to the new 2018 FIGO staging, clinicians
usually use preoperative MRI and biopsy to assist the diagnosis and staging of
cervical cancer.2 However, histopathological information can only be obtained through
invasive methods. The excisional biopsy often disrupts the original
microenvironment of the tumor and compromises further pathological findings.3 Meanwhile,
imaging assessments performed by radiologists heavily rely on their clinical
experience, resulting in large subjective variations. Especially, the
differentiation of stages IIA and IIB are nearly unachievable through MRI
images4, which might be addressed by employing radiomics. Radiomics can extract high throughput image
features that shows great potential in diagnosis, response to therapy and prognosis.5 In this
retrospective study, we aimed to explore intratumoral and peritumoral multi-parameter MRI-based radiomics to establish
imaging-based classifiers for distinguishing stage IIA vs.
stage IIB
of cervical cancer.
Methods
Two hundred and eight cases with histologically confirmed
cervical cancer from three institutions (Hospital 1: n = 67; Hospital 2: n =
36; Hospital 3: n = 105) were enrolled in this study. All the cases were
randomly divided into the training cohort (n=145) and the validation cohort
(n=63). The design of this study is shown in Figure 1. Four clinical
factors including age, human papillomavirus, squamous cell carcinoma antigen,
and carcinoma embryonic antigen were collected. Univariate and multivariate
logistic regression analyses were respectively applied to these factors for the
clinical model development. For the multi-parametric MRI acquisition,
diffusion-weighted imaging (DWI), contrast-enhanced T1-weighted, and T2-weighted
imaging were performed. MRI standardization processing including offset
correction, gray level normalization, and resampling of voxels were used to
reduce the gray difference among different manufacturers, imaging protocol, and
patients. Two radiologists (6 and 10 years of experience, respectively)
independently and double-blindly determined the clinical stage from MRI and
segmented the volume of interest (VOI). The final version was obtained through
discussion and corrected for the cases with large differences in the
definitions from the radiologists. Peritumoral VOIs were defined from the final VOIs dilated by
a circular structural element with a radius size (number of a pixel) of 3. An
open-source package PyRadiomics6 was used for radiomics feature
extraction. Then, a total of 1130 radiomics features were extracted from each
VOI of the original and derived MR images using the Laplacian of gaussian and
wavelet filter. After the feature standardization with Z-score algorithm, the
Pearson correlation coefficient analysis and recursive feature elimination
algorithm were adopted successively to obtain the well-representative features.
Different classifiers were compared to develop the optimal radiomics signature
across 5-fold cross validation. The calibration curves and decision curve
analysis were conducted to evaluate the clinical utility of the optimal model.
Results
The comparison results of the predictive models
are shown in Table 1. Only age (odds ratio, 0.962; 95% confidence
interval, 0.925−0.999; P=0.047*) was
found to be significantly associated with the stage and used to construct the
clinical model. The peritumoral radiomics models were superior to the
intratumoral radiomics models, regardless of single sequence model or fusion
model (all P <0.001*). DWI-based peritumoral radiomics model
performed best with the AUCs of 0.975 (0.965−0.983) and 0.899 (0.880−0.916) in the training and validation cohort, respectively.
There was no significant difference between the validation AUCs of DWI-based
and fusion peritumoral radiomics model (0.899 vs. 0.895, P =0.566). Figure
2 illustrates the superior performance of this model.
Discussion
Distinguishing IIA and IIB stages is essential
because the therapeutic regimens and follow-up care are vastly different for
each of these conditions. We explored the intratumoral and peritumoral regions
of cervical cancer in differentiating IIA and IIB stages, and the results revealed
that the most predictable features could be obtained from the peritumoral regions
with 3 pixel dilation distances in the DWI images. Parametrial
involvement (PMI) is the main differentiation between IIA and IIB stages.
Previous studies showed that DWI is
regarded as the most efficient tool to be employed in the detection of PMI. The results can be interpreted
considering that DWI images can detect early pathological changes associated
with changes in water content in tissues and can provide good functional
information7,8. Similar to our previous finding, this study suggested
that the peritumoral radiomic signatures have a much better discrimination
performance in distinguishing IIA and IIB stage, which can be partly explained
by that the fact that peritumoral region provides more information about
parametrial infiltration 9,10.
Conclusion
MRI-based
radiomics model from peritumoral regions outperformed radiologists for the
preoperative diagnosis of IIA and IIB stage. A noninvasive and reliable
supplementary approach was provided to precise preoperative staging, which can
help optimize individualized treatment plans for patients with cervical cancer.Acknowledgements
No acknowledgement found.References
Reference
1. Cohen PA, Jhingran A, Oaknin A, et
al. Cervical cancer. Lancet. 2019;393(10167):169-182.
2. Bhatla N, Berek JS, Cuello Fredes M,
et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol
Obstet. 2019;145(1):129-135.
3. Weyl A, Illac C, Lusque A, et al.
Prognostic value of lymphovascular space invasion in early-stage cervical
cancer. Int J Gynecol Cancer. 2020;30(10):1493-1499.
4. Manganaro L, Lakhman Y, Bharwani N,
et al. Correction to: Staging, recurrence and follow-up of uterine cervical
cancer using MRI: Updated Guidelines of the European Society of Urogenital
Radiology after revised FIGO staging 2018. Eur Radiol. 2022;32(1):738.
5. O'Connor JP, Rose CJ, Waterton JC, et
al. Imaging intratumor heterogeneity: role in therapy response, resistance, and
clinical outcome. Clin Cancer Res. 2015;21(2):249-257.
6. van Griethuysen J, Fedorov A, Parmar
C, et al. Computational Radiomics System to Decode the Radiographic Phenotype.
Cancer Res. 2017; 77(21):e104-e107.
7. Park JJ, Kim CK, Park SY, et al.
Value of diffusion-weighted imaging in predicting parametrial invasion in stage
IA2-IIA cervical cancer. Eur Radiol. 2014;24(5):1081-1088.
8. Woo S, Suh CH, Kim SY, et al.
Magnetic resonance imaging for detection of parametrial invasion in cervical
cancer: An updated systematic review and meta-analysis of the literature
between 2012 and 2016. Eur Radiol. 2018;28(2):530-541.
9. Wang X, Zhao X, Li Q, et al. Can peritumoral
radiomics increase the efficiency of the prediction for lymph node metastasis
in clinical stage T1 lung adenocarcinoma on CT? Eur Radiol.
2019;29(11):6049-6058.
10. Sun C, Tian X, Liu Z, et al. Radiomic
analysis for pretreatment prediction of response to neoadjuvant chemotherapy in
locally advanced cervical cancer: A multicentre study. EBioMedicine.
2019;46:160-169.